Related Experiment Video
Updated: Aug 14, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src
1Laboratory of Integrin Signaling and Tumorigenesis, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
Abstract:
KAI1/CD82, a tetraspanin protein, was first identified as a metastasis suppressor in prostate cancer. How loss of CD82 expression promotes cancer metastasis is unknown. Restoration of CD82 expression to physiological levels in the metastatic prostate cell line PC3 inhibits integrin-mediated cell migration and invasion, but does not affect integrin expression. Integrin-dependent activation of the receptor kinase c-Met is dramatically reduced in CD82-expressing cells, as is c-Met activation by its ligand HGF/SF. CD82 expression also reduced integrin-induced activation and phosphorylation of the cytoplasmic tyrosine kinase Src, and its downstream substrates p130Cas and FAK Y861. Inhibition of c-Met expression or Src kinase function reduced matrigel invasion of PC3 cells to the same extent as CD82 expression. These data indicate that CD82 functions to suppress integrin-induced invasion by regulating signaling to c-Met and Src kinases, and suggests that CD82 loss may promote metastasis by removing a negative regulator of c-Met and Src signaling.
Insights
Loss of CD82 (KAI1) protein suppresses prostate cancer metastasis by inhibiting integrin-mediated cell invasion. CD82 regulates signaling pathways involving c-Met and Src kinases, crucial for cancer cell movement.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- KAI1/CD82, a tetraspanin protein, is recognized as a metastasis suppressor in prostate cancer.
- The precise mechanisms by which CD82 loss promotes cancer metastasis remain largely unknown.
Purpose of the Study:
- To elucidate the functional role of CD82 in regulating prostate cancer cell migration and invasion.
- To investigate the signaling pathways influenced by CD82 expression in prostate cancer.
Main Methods:
- Utilized the metastatic prostate cancer cell line PC3 with restored CD82 expression.
- Assessed integrin-mediated cell migration and invasion.
- Analyzed the activation status of c-Met and Src kinase signaling pathways.
- Examined the phosphorylation of downstream substrates like p130Cas and FAK Y861.
Main Results:
- Restoring CD82 expression inhibited integrin-mediated cell migration and invasion without altering integrin levels.
- CD82 expression significantly reduced integrin-dependent activation of c-Met and Src kinases.
- Inhibition of c-Met or Src kinase function mimicked the anti-invasive effects of CD82 expression.
Conclusions:
- CD82 suppresses integrin-induced invasion by negatively regulating signaling pathways involving c-Met and Src kinases.
- Loss of CD82 may promote prostate cancer metastasis by removing a critical negative regulator of c-Met and Src signaling.
More Related Videos
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades

